Non-coding RNAs as predictive factors of oncological outcomes in plasma cell myeloma
Current preclinical and clinical data on ncRNAs as predictive biomarkers of response to PCM therapies are synthesized, the most promising molecules and their mechanisms of action are identified, key methodological limitations are highlighted, and a translational validation framework necessary for clinical implementatio...